Concepedia

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma

Andrew Wirth, John F. Seymour, Rodney J. Hicks, Robert S. Ware, Richard Fisher, Miles Prince, Michael MacManus, G.B. Ryan, Henry Januszewicz, Max Wolf

The American Journal of Medicine · 2002 · 170 citations · 33 references

DOI

Concepts

References

33

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Tim Lister, D. Crowther, S.B. Sutcliffe et al. · Journal of Clinical Oncology · 1989 · 1.6K citations

, , +14

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

Thomas P. Miller, Steve Dahlberg, J. Robert Cassady et al. · New England Journal of Medicine · 1998 · 1K citations · Full text

, , +11

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([<sup>18</sup>F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [<sup>18</sup>F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 2001 · 466 citations

, , +17

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.

Michael P. Mac Manus, Richard T. Hoppe · Journal of Clinical Oncology · 1996 · 401 citations

, , +15

Extranodal malignant lymphoma: detection with FDG PET versus CT.

Florian Moog, Markus Bangerter, C. G. Diederichs et al. · Radiology · 1998 · 323 citations

, , +17